MENU
Education Stock symbols

(TSX = xxx.TO, TSX-V = xxx.V)

ACST.V - Acasti Pharma Inc
7.87 0.28 (0%)  
Open: Prev Close:
High: Low:
Volume: Market Cap:
Year High: Year Low:
Stock Technical Analysis
Overall       
Targets Six months: 1.03    One year: 1.31
Supports Support1: 0.50   Support2: 0.42
Resistances Resistance1: 0.88    Resistance2: 1.12 
Pivot Point 0.60 
Moving Averages MA(5): 0.59      MA(20): 0.62 

MA(100): 0.73      MA(250): 0.97 
MACD MACD(12,26): -0.06      Signal(12,26,9): -0.07 
Stochastic Oscillator %K(14,3): 38.60      %D(3): 43.14 
RSI RSI(14): 38.52 
52-Week High: 1.66  Low: 0.47  Change(%): -61.3
Average Volume(K) 3-Month: 558  10-Days: 427
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
ACST.V has closed above bottom band by 41.0%. Bollinger Bands are 19.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock Technical Analysis Charts
Company news
Fri, 07 Jul 2023
Acasti Pharma Announces 1-for-6 Reverse Stock Split - PR Newswire

Tue, 31 Oct 2023
Aker BioMarine acquires IP & equipment from Acasti Pharma Inc. - NutraIngredients-usa.com

Sat, 20 Apr 2024
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate - Simply Wall St

Fri, 23 Jun 2023
After laying off most staff, Acasti insists it's still on track - Fierce Biotech

Mon, 12 Feb 2024
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Fri, 23 Jun 2023
Acasti Pharma Reports Fiscal Year 2023 Operational Results - PR Newswire

Stoxline Canada

Stock Chart Toronto

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E
P/E Growth Ratio
P/BV
P/S
P/CF